Veterinary Medicines

Tenazym perorálna suspenzia

Authorised
  • Tetracycline hydrochloride
  • NEOMYCIN SULFATE
  • Prednisolone acetate
  • Chymotrypsin
  • Trypsin
  • Papain
Download as PDF

Product identification

Medicine name:
Tenazym perorálna suspenzia
Active substance:
  • Tetracycline hydrochloride
  • NEOMYCIN SULFATE
  • Prednisolone acetate
  • Chymotrypsin
  • Trypsin
  • Papain
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use
  • Cutaneous use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • NEOMYCIN SULFATE
    22.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Prednisolone acetate
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Chymotrypsin
    120.00
    FIP
    /
    1.00
    millilitre(s)
  • Trypsin
    12.00
    FIP
    /
    1.00
    millilitre(s)
  • Papain
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA53
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Available in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/084/97-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 24/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."